Monoclonal antibodies against the human C5a receptor offer new therapeutic prospects for complement inhibition.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Muscle membrane repair and inflammatory attack in dysferlinopathy
Skeletal Muscle Open Access 01 March 2011
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Lee, H. et al. Nat. Biotechnol. 24, 1279–1284 (2006).
Huber-Lang, M. et al. Nat Med. 12, 682–687 (2006).
Wang, Y., Rollins, S.A., Madri, J.A. & Matis, L.A. Proc. Natl. Acad. Sci. USA 92, 8955–8959 (1995).
Thomas, T.C. et al. Mol. Immunol. 33, 1389–1401 (1996).
Frei, Y., Lambris, J.D. & Stockinger, B. Mol. Cell Probes 1, 141–149 (1987).
Peng, T. et al. J. Clin. Invest. 115, 1590–1600 (2005).
Gerard, N.P. et al. J. Biol. Chem. 280, 39677–39680 (2005).
Kohl, J. et al. J. Clin. Invest. 116, 783–796 (2006).
Dobrina, A. et al. Blood 99, 185–192 (2002).
Hillmen, P. et al. N. Engl. J. Med. 355, 1233–1243 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wang, Y. Complementary therapies for inflammation. Nat Biotechnol 24, 1224–1226 (2006). https://doi.org/10.1038/nbt1006-1224
Issue Date:
DOI: https://doi.org/10.1038/nbt1006-1224
This article is cited by
-
Muscle membrane repair and inflammatory attack in dysferlinopathy
Skeletal Muscle (2011)